乳腺原发性神经内分泌癌:改变范式
1Surgical Oncology & Breast Services, The Mission Hospital, Durgapur, West Bengal 713212 India.
Indian journal of surgical oncology
|March 21, 2025
概括
神经内分泌乳腺癌是一种罕见的恶性瘤. 目前的定义侧重于特定标记物表达和组织病理学,但缺乏明确的治疗指南.
科学领域:
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 神经内分泌癌是一种非常罕见的乳腺恶性瘤.
- 与其他器官相比,它们在乳房中的发生率显著较少.
- 不断变化的定义使标准化诊断和治疗变得复杂.
研究的目的:
- 总结目前对神经内分泌乳腺癌的理解和定义.
- 突出基于世界卫生组织 (WHO) 分类的诊断标准.
主要方法:
- 审查当前文献和世界卫生组织 (WHO) 的分类标准.
- 诊断标记和组织病理特征的分析.
主要成果:
- 神经内分泌乳腺癌是由表达90%以上神经内分泌标记物的恶性病变定义的 (例如,synaptophysin,chromogranin A).
- 典型的组织病理学特征对于诊断至关重要.
- 排除标准包括固体乳头癌和高细胞类型的粘膜癌.
结论:
- 神经内分泌乳腺癌的罕见性和不断变化的定义带来了诊断挑战.
- 目前的诊断标准依赖于特定的标记物表达和组织病理学,但不包括某些瘤类型.
- 由于缺乏具体的治疗指南,需要进一步研究.
相关概念视频
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Treatment Resistant Cancers
2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K


